Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication

Figure 1 Flow schematic of the study included in intention-to-treat and per-protocol analyses. ¹Rabeprazole 20 mg twice a day, amoxicillin 1 g twice a day, moxifloxacin 400 mg once a day, clarithromycin 500 mg twice a day, metronidazole 500 mg twice a day. MBST: 14-d moxifloxacin-based sequential therapy; Hybrid: 14-d hybrid therapy; ITT: Intention-to-treat; PP: Per-protocol.